ResMed Inc.RMDNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR-6.8%
5Y CAGR+2.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-6.8%/yr
Quarterly compound
5Y CAGR
+2.4%/yr
Recent deceleration
Percentile
P82
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.41% |
| Q3 2025 | -2.24% |
| Q2 2025 | 8.08% |
| Q1 2025 | 1.53% |
| Q4 2024 | 1.10% |
| Q3 2024 | -1.32% |
| Q2 2024 | 5.34% |
| Q1 2024 | 3.49% |
| Q4 2023 | -0.32% |
| Q3 2023 | -7.40% |
| Q2 2023 | 5.35% |
| Q1 2023 | 7.93% |
| Q4 2022 | 9.15% |
| Q3 2022 | -0.49% |
| Q2 2022 | 6.85% |
| Q1 2022 | -1.60% |
| Q4 2021 | 4.89% |
| Q3 2021 | -2.63% |
| Q2 2021 | 13.11% |
| Q1 2021 | -5.32% |
| Q4 2020 | 6.59% |
| Q3 2020 | -3.87% |
| Q2 2020 | -4.09% |
| Q1 2020 | 0.59% |
| Q4 2019 | 2.38% |
| Q3 2019 | -2.42% |
| Q2 2019 | 4.30% |
| Q1 2019 | 1.83% |
| Q4 2018 | 9.69% |
| Q3 2018 | -6.06% |
| Q2 2018 | 6.03% |
| Q1 2018 | -2.58% |
| Q4 2017 | 5.54% |
| Q3 2017 | -2.77% |
| Q2 2017 | 7.31% |
| Q1 2017 | -1.04% |
| Q4 2016 | 8.11% |
| Q3 2016 | -5.15% |
| Q2 2016 | 10.53% |
| Q1 2016 | 3.96% |